top of page

2023 Abstract Posters

hcctag_poster_draft_12_13feb2023_A. Mavash.jpg
A prospective, multicenter, open-label,clinical trial design to evaluate the safety and efficacy of Y90 resin microspheres for treatment of unresectable hepatocellular carcinoma (HCC): Duration Of Objective Response with arterial
Yttrium-90 (DOORwaY90)
Kelley_HIMALAYA Timing of AEs poster_HCC-TAG_Final Diane Mascioli (1).jpg

Adverse event profiles and time to onset and

resolution with tremelimumab plus durvalumab

in patients with unresectable hepatocellular

carcinoma in the Phase 3 HIMALAYA trial

Poster HCC TAG Cynthia De la Garza.jpg
Radiation Segmentectomy for Early-Stage Hepatocellular Carcinoma in Patients with Non-Alcoholic Steatohepatitis versus Chronic Viral Hepatitis
Yarchoan_HIMALAYA Viral Etiology poster HCC-TAG_Final Diane Mascioli.jpg
Impact of viral etiology in the Phase 3 HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma
bottom of page